8 4 • O U T PA T I E N T S U R G E R Y M A G A Z I N E • J U N E 2 0 1 9
Pacira Pharmaceuticals
Exparel
exparel.com
I know Exparel
isn't new, but it
continues to grow
in importance and
relevance. Surgeons
are very interested
in opioid-sparing
anesthesia these
days, and for good
reason. Quicker
recovery, shorter
hospital stays and,
in a societally topi-
cal way, fewer opioid prescriptions are some of the major ones. Pacira
makes a liposomal bupivacaine you can inject in and around the inci-
sion to reduce the patient's need for taking supplemental analgesia for
72 hours. It freezes the trocar sites, freezes the small incision site and
probably accelerates discharge. It's definitely cutting down on the vol-
ume of opioid prescriptions, and that is so important right now.
